| Acute decompensated heart failure. | |
| | |
MedLine Citation:
|
PMID: 18629381 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Acute decompensated heart failure is the most common cause of hospitalization for patients older than 65 years of age. Although treatment of this condition has improved over the past two decades, the specific approach to patients in the acute setting has not evolved in the same way. A patient facing acute decompensation is experiencing a serious medical condition that is associated with a poor prognosis. In addition, acute decompensated heart failure results in significant costs to the health care system. Significant morbidity and mortality are associated with patients who are readmitted within a year of the first hospitalization. Because of this important problem, further research on improving the prognosis for this condition is warranted. The present article will focus on the risk factors associated with acute decompensation and the importance of this condition, both on prognosis and economics. |
| | |
Authors:
|
Serge Lepage |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Canadian journal of cardiology Volume: 24 Suppl B ISSN: 1916-7075 ISO Abbreviation: Can J Cardiol Publication Date: 2008 Jul |
Date Detail:
|
Created Date: 2008-07-16 Completed Date: 2008-11-17 Revised Date: 2010-09-21 |
Medline Journal Info:
|
Nlm Unique ID: 8510280 Medline TA: Can J Cardiol Country: Canada |
Other Details:
|
Languages: eng Pagination: 6B-8B Citation Subset: IM |
Affiliation:
|
Cardiology Division, Faculty of Medicine, University of Sherbrooke, Sherbrooke, Quebec. serge.lepage@USherbrooke.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Age Distribution Aged Aged, 80 and over Canada / epidemiology Cardiotonic Agents / therapeutic use Diuretics / therapeutic use Drug Therapy, Combination Female Heart Failure / diagnosis*, drug therapy, epidemiology* Hospital Costs* Hospitalization / economics, statistics & numerical data Humans Incidence Male Natriuretic Peptide, Brain / therapeutic use Patient Readmission / economics, statistics & numerical data Risk Assessment Severity of Illness Index Sex Distribution Survival Analysis |
| Chemical | |
Reg. No./Substance:
|
0/Cardiotonic Agents; 0/Diuretics; 114471-18-0/Natriuretic Peptide, Brain |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Proteomic analysis of skin invasion by blood fluke larvae.
Next Document: Current treatment options for early management in acute decompensated heart failure.